Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report

Although various therapeutic agents have been tried for coronavirus disease-2019 (COVID-19) and evidence has accumulated, the risk of secondary infection is increased by underlying disease and immunosuppressive drugs. We report a case of pneumococcal meningitis in a patient with severe COVID-19 who...

Descripción completa

Detalles Bibliográficos
Autores principales: Murayama, Yoshiaki, Ishimine, Tomohiko, Sasano, Mikio, Todaka, Takafumi, Matsumoto, Takashi, Shimabukuro, Taiga, Yonaha, Risa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981263/
https://www.ncbi.nlm.nih.gov/pubmed/36896031
http://dx.doi.org/10.1016/j.idcr.2023.e01727
Descripción
Sumario:Although various therapeutic agents have been tried for coronavirus disease-2019 (COVID-19) and evidence has accumulated, the risk of secondary infection is increased by underlying disease and immunosuppressive drugs. We report a case of pneumococcal meningitis in a patient with severe COVID-19 who was receiving dexamethasone and tocilizumab. The patient's symptoms improved with appropriate diagnosis and antimicrobial therapy, and she fortunately returned to society without any neurological sequelae of meningitis.

Ejemplares similares